Rotation thromboelastometry and the hypercoagulable state in Cushing's syndrome

Clinical Endocrinology

Volumn 81, Issue 5, 2014, Pages 657-664

  Alves Coelho, Maria Caroline ^a   Vieira Neto, Leonardo ^a,b   Kasuki, Leandro ^a,c   Wildemberg, Luiz Eduardo ^a   Dos Santos, Camila Vicente ^a   Castro, Gizele ^a   Gouvêa, Glauber ^a   Veloso, Orlando Carlos Gloria ^d   Gadelha, Telma ^a   Gadelha, Mônica R ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Lagoa Federal Hospital   (Brazil)

^c Bonsucesso Federal Hospital   (Brazil)

^d CDPI Image Diagnosis Center   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; C REACTIVE PROTEIN; D DIMER; FIBRINOGEN; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD ANALYSIS EQUIPMENT; BLOOD CLOTTING; BLOOD GROUP ABO SYSTEM; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CUSHING SYNDROME; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; HYPERCOAGULABILITY; HYPERTENSION; OBESITY; PARTIAL THROMBOPLASTIN TIME; SMOKING; THROMBOCYTE; THROMBOELASTOGRAPHY; BLOOD; CASE CONTROL STUDY; COMPLICATION; HEMOSTASIS; MALE; MIDDLE AGED; PROCEDURES; ROTATION; THROMBOPHILIA;

ADULT; BLOOD COAGULATION; CASE-CONTROL STUDIES; CUSHING SYNDROME; FEMALE; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; ROTATION; THROMBELASTOGRAPHY; THROMBOPHILIA;

EID: 84912125267     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12491     Document Type: Article

References (34)

1. Etxabe, J., &, Vazquez, J.A., (1994) Morbidity and mortality in Cushing's disease: an epidemiological approach. Clinical Endocrinology, 40, 479-484.
2. Manetti, L., Bogazzi, F., Giovannetti, C., et al,. (2010) Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing's syndrome: results from a prospective study before and after surgery. European Journal of Endocrinology, 163, 783-791.
3. Boscaro, M., Sonino, N., Scarda, A., et al,. (2002) Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism, 87, 3662-3666.
4. Casonato, A., Pontara, E., Boscaro, M., et al,. (1999) Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome. Blood Coagulation & Fibrinolysis, 10, 145-151.
5. Van Zaane, B., Nur, E., Squizzato, A., et al,. (2009) Hypercoagulable state in Cushing's syndrome: a systematic review. Journal of Clinical Endocrinology and Metabolism, 94, 2743-2750.
6. Patrassi, G.M., Dal Bo Zanon, R., Boscaro, M., et al,. (1985) Further studies on the hypercoagulable state of patients with Cushing's syndrome. Thrombosis and Haemostasis, 54, 518-520.
7. Fatti, L.M., Bottasso, B., Invitti, C., et al,. (2000) Markers of activation of coagulation and fibrinolysis in patients with Cushing's syndrome. Journal of Endocrinological Investigation, 23, 145-150.
8. Kastelan, D., Dusek, T., Kraljevic, I., et al,. (2009) Hypercoagulability in Cushing's syndrome: the role of specific haemostatic and fibrinolytic markers. Endocrine, 36, 70-74.
9. Tripodi, A., Chantarangkul, V., Martinelli, I., et al,. (2004) A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism. Blood, 104, 3631-3634.
10. Spiezia, L., Marchioro, P., Radu, C., et al,. (2008) Whole blood coagulation assessment using rotation thrombelastogram thromboelastometry in patients with acute deep vein thrombosis. Blood Coagulation & Fibrinolysis, 19, 355-360.
11. Engstrom, M., Rundgren, M., &, Schott, U., (2010) An evaluation of monitoring possibilities of argatroban using rotational thromboelastometry and activated partial thromboplastin time. Acta Anaesthesiologica Scandinavica, 54, 86-91.
12. Thorson, C.M., Van Haren, R.M., Ryan, M.L., et al,. (2013) Persistence of hypercoagulable state after resection of intra-abdominal malignancies. Journal of the American College of Surgeons 216, 580-589; discussion 589-590.
13. Daudel, F., Kessler, U., Folly, H., et al,. (2009) Thromboelastometry for the assessment of coagulation abnormalities in early and established adult sepsis: a prospective cohort study. Critical Care, 13, R42.
14. Schreiber, M.A., Differding, J., Thorborg, P., et al,. (2005) Hypercoagulability is most prevalent early after injury and in female patients. Journal of Trauma, 58, 475-480; discussion 480-471.
15. Papa, M.L., Capasso, F., Pudore, L., et al,. (2007) Thromboelastographic profiles as a tool for thrombotic risk in digestive tract cancer. Experimental Oncology, 29, 111-115.
16. Karlsson, O., Sporrong, T., Hillarp, A., et al,. (2012) Prospective longitudinal study of thromboelastography and standard hemostatic laboratory tests in healthy women during normal pregnancy. Anesthesia and Analgesia, 115, 890-898.
17. Abrahams, J.M., Torchia, M.B., McGarvey, M., et al,. (2002) Perioperative assessment of coagulability in neurosurgical patients using thromboelastography. Surgical Neurology, 58, 5-11; discussion 11-12.
18. Nieman, L.K., Biller, B.M., Findling, J.W., et al,. (2008) The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism, 93, 1526-1540.
19. American Diabetes, A., (2013) Standards of medical care in diabetes-2013. Diabetes Care, 36 (Suppl 1), S11-S66.
20. Berlin, I., Lin, S., Lima, J.A., et al,. (2012) Smoking status and metabolic syndrome in the multi-ethnic study of atherosclerosis. A cross-sectional study. Tobacco Induced Diseases, 10, 9.
21. Lahera Vargas, M., &, da Costa, C.V., (2009) Prevalence, etiology and clinical findings of Cushing's syndrome. Endocrinología y nutriciõn: õrgano de la Sociedad Española de Endocrinología y Nutriciõn, 56, 32-39.
22. Perez Garcia, L., Anda, E., &, Rojo, J., (2012) Cushing s syndrome: twenty-five years of clinical experience in Navarre. Anales del Sistema Sanitario de Navarra, 35, 461-467.
23. Magiakou, M.A., Smyrnaki, P., &, Chrousos, G.P., (2006) Hypertension in Cushing's syndrome. Best Practice & Research: Clinical Endocrinology & Metabolism, 20, 467-482.
24. Cicala, M.V., &, Mantero, F., (2010) Hypertension in Cushing's syndrome: from pathogenesis to treatment. Neuroendocrinology, 92 (Suppl 1), 44-49.
25. van der Pas, R., de Bruin, C., Leebeek, F.W., et al,. (2012) The hypercoagulable state in Cushing's disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy. Journal of Clinical Endocrinology and Metabolism, 97, 1303-1310.
26. Erem, C., Nuhoglu, I., Yilmaz, M., et al,. (2009) Blood coagulation and fibrinolysis in patients with Cushing's syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels. Journal of Endocrinological Investigation, 32, 169-174.
27. Daidone, V., Boscaro, M., Pontara, E., et al,. (2011) New insight into the hypercoagulability of Cushing's syndrome. Neuroendocrinology, 93, 121-125.
28. O'Donnell, J., &, Laffan, M.A., (2001) The relationship between ABO histo-blood group, factor VIII and von Willebrand factor. Transfusion Medicine (Oxford, England), 11, 343-351.
29. Reddy, N.M., Hall, S.W., &, MacKintosh, F.R., (1999) Partial thromboplastin time: prediction of adverse events and poor prognosis by low abnormal values. Archives of Internal Medicine, 159, 2706-2710.
30. Edson, J.R., Krivit, W., &, White, J.G., (1967) Kaolin partial thromboplastin time: high levels of procoagulants producing short clotting times or masking deficiencies of other procoagulants or low concentrations of anticoagulants. Journal of Laboratory and Clinical Medicine, 70, 463-470.
31. Koutroumpi, S., Daidone, V., Sartori, M.T., et al,. (2013) Venous thromboembolism in patients with Cushing's syndrome: need of a careful investigation of the prothrombotic risk profile. Pituitary, 16, 175-181.
32. Koster, T., Rosendaal, F.R., Reitsma, P.H., et al,. (1994) Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms-the Leiden Thrombophilia Study (LETS). Thrombosis and Haemostasis, 71, 719-722.
33. Rees, D.A., Hanna, F.W., Davies, J.S., et al,. (2002) Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission. Clinical Endocrinology, 56, 541-551.
34. Akay, O.M., Ustuner, Z., Canturk, Z., et al,. (2009) Laboratory investigation of hypercoagulability in cancer patients using rotation thrombelastography. Medical Oncology, 26, 358-364.